⌘K

Login Start Free

Home/Filings/4/0001232787-07-000004

4//SEC Filing

IOMED INC 4

Accession 0001232787-07-000004

CIK 0001041652operating

View on SEC.gov Company Profile

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 1:30 PM ET

Size

25.6 KB

Accession

0001232787-07-000004

Insider Transaction Report

Form 4

Period: 2007-08-09

Director

Transactions

Disposition to Issuer
Stock Option
2007-08-09$1.72/sh−15,000$25,800→ 0 total
Exercise: $1.72From: 2007-08-09Exp: 2007-08-09→ Common stock (15,000 underlying)
Disposition to Issuer
Stock option
2007-08-09$2.25/sh−10,000$22,500→ 0 total
Exercise: $2.25From: 2007-08-09Exp: 2007-08-09→ Common stock (10,000 underlying)
Disposition to Issuer
Stock Option
2007-08-09$3.88/sh−10,000$38,750→ 0 total
Exercise: $3.88From: 2007-08-09Exp: 2007-08-09→ Common stock (10,000 underlying)

SEMBER MICHAEL T

Director

Transactions

Disposition to Issuer
Stock option
2007-08-09$2.25/sh−10,000$22,500→ 0 total
Exercise: $2.25From: 2007-08-09Exp: 2007-08-09→ Common stock (10,000 underlying)
Disposition to Issuer
Stock Option
2007-08-09$1.72/sh−15,000$25,800→ 0 total
Exercise: $1.72From: 2007-08-09Exp: 2007-08-09→ Common stock (15,000 underlying)
Disposition to Issuer
Stock Option
2007-08-09$3.88/sh−10,000$38,750→ 0 total
Exercise: $3.88From: 2007-08-09Exp: 2007-08-09→ Common stock (10,000 underlying)

Director

Transactions

Disposition to Issuer
Stock option
2007-08-09$2.25/sh−10,000$22,500→ 0 total
Exercise: $2.25From: 2007-08-09Exp: 2007-08-09→ Common stock (10,000 underlying)
Disposition to Issuer
Stock Option
2007-08-09$1.72/sh−15,000$25,800→ 0 total
Exercise: $1.72From: 2007-08-09Exp: 2007-08-09→ Common stock (15,000 underlying)
Disposition to Issuer
Stock Option
2007-08-09$3.88/sh−10,000$38,750→ 0 total
Exercise: $3.88From: 2007-08-09Exp: 2007-08-09→ Common stock (10,000 underlying)

Footnotes (2)

[F1]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. A cash payment representing the difference between the exercise price of the option and the merket value of the underlying Iomed common stock on the effective date of the merger ($2.75 per share) was made.
[F2]This option was cancelled pursuant to the merger between issuer, ReAble Therapeutics, Inc. and Spartan Acquisition Corp. There was no cash payment made because the option price was below the market value of the underlying Iomed common stock on the effective date of the merger ($2.75 per share).

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IOMED INC

CIK 0001041652

Entity typeoperating

IncorporatedUT

Related Parties

1

filerCIK 0001041652

Filing Metadata

Form type: 4
Filed: Aug 12, 8:00 PM ET
Accepted: Aug 13, 1:30 PM ET
Size: 25.6 KB

View on SEC.gov